Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 13/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 7/20 | 0.44 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3824145 | 0.77 | CCR1 (0.42) | ADORA2AADORA1ADORA2BLMNAKMT2A | |
| SCHEMBL29248279 | 0.72 | ADORA2A (0.47) | ADORA2AADORA1ADORA2BADORA3LMNA | |
| SCHEMBL28360928 | 0.72 | ADORA2A (0.44) | ADORA2AADORA1ADORA2BADORA3LMNA | |
| SCHEMBL2327791 | 0.69 | LMNA (0.63) | ADORA2AADORA1ADORA2BADORA3LMNA | |
| SCHEMBL28357115 | 0.68 | ADORA2A (0.46) | ADORA2AADORA1ADORA2BADORA3LMNA | |
| SCHEMBL335715 | 0.66 | ALDH1A1 (0.36) | KMT2AMEN1 | |
| SCHEMBL3556547 | 0.65 | ADORA2A (0.48) | ADORA2AADORA1ADORA2BADORA3LMNA | |
| SCHEMBL17427082 | 0.65 | ADORA2A (0.46) | ADORA2AADORA1LMNAKMT2A | |
| SCHEMBL27971654 | 0.64 | EGLN2 (0.34) | — | |
| SCHEMBL16579755 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118317965-A | Adenosine receptor antagonists | 交信医药研发公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118317965-A | Adenosine receptor antagonists | 交信医药研发公司 | 2024-07-09 | — | — | CN | disclosed |